alzheimer's bapineuzumab clinical trial J and J Janssen Alzheimer Immunotherapy PFE pfizer Pfizer Bapineuzumab Fails, All Clinical Trials Discontinued The clinical findings together with the determination to discontinue the bapineuzumab IV programme inward patients amongst mild-to-moderate ... Edit